European Healthtech startup funding raised during November 2022.
In November 2022, 60 European Healthtech companies raised a combined €729M across 62 funding rounds, down 29.5% versus November 2021. UK led by capital raised, and Bertelsmann Investments was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| TauRx Pharmaceuticals | Other | Nov 2022 | €115M |
| Demant AS | Debt | Nov 2022 | €115M |
| Osler Diagnostics | Series C | Nov 2022 | €85M |
| CatalYm | Series C |
9 exits · €2.6B disclosed.
| Immucor | Acquisition | Nov 2022 | €2.0B |
| Neogene Therapeutics | Acquisition | Nov 2022 | €310M |
| Focus-X Therapeutics | Acquisition | Nov 2022 | €237M |
| BModesto | Acquisition | Nov 2022 | €75M |
| Nov 2022 |
| €50M |
| Novadip Biosciences | Series B | Nov 2022 | €40M |
| Opna Bio | Series A | Nov 2022 | €37M |
| Temedica | Series B | Nov 2022 | €25M |
| Eagle Genomics | Other | Nov 2022 | €20M |
| Turbine | Series A | Nov 2022 | €20M |
| Accession Therapeutics | Other | Nov 2022 | €19M |
| NRG Therapeutics | Series A | Nov 2022 | €18M |
| Healios | Other | Nov 2022 | €16M |
| Enzyre | Series A | Nov 2022 | €12M |
| Re-Vana Therapeutics | Series A | Nov 2022 | €11M |
| Qunomedical | Series A | Nov 2022 | €10M |
